Resolution of in flammation: state of the art, definitions and terms
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
A recent focus meeting on Controlling Acute Inflammation was held in London, April 27–28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti‐inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter‐regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation‐associated diseases based on endogenous agonists of resolution.—Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., Wallace, J. L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325–332 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The process of inflammation resolution involves not only passive mechanisms, e.g., dissipation of chemotactic gradient or initial danger signals, but also active biochemical pathways [103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 3×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
Background(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 2×
“1C), may lead to prolonged inflammation and the inability for the tissue to return to homeostasis (26) and complete the full life-cycle per se of the neutrophils and mononuclear cells recruited to the tissue.”
BackgroundSelf-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 1×
“Nalp3 occurs in an inflammasome complex with caspase-1, ASC, cardinal, and Nalp2 ( 12 ).”
BackgroundMolecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684 · cited 1×
“Uric acid is the causative agent of gout but is also released by damaged cells, possibly as a general signal for inflammation (15).”
BackgroundSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×
“Additionally, the widely used aspirin jump-starts resolution by making up for its loss in prostaglandin production, which plays key roles in resolution, by instead generating the epimeric version of lipid mediators (25), such as the aspirin-triggered lipoxins (recently reviewed in ref.”
BackgroundSelf-citationNegative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 8×
“In effect, TLRs sow the seeds of their own destruction, and the role of negative regulators clearly indicates how robust the TLR system is.”
BackgroundInfluentialSelf-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“enzymes are expressed (31), and whether it is resolving”
BackgroundSelf-citationRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401 · cited 4×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
BackgroundInfluentialInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Self-citation
Cited by
Items 501–600 of 1,000
Dalli, J., Rosignoli, G., Hayhoe, R. P. G., Edelman, A., & Perretti, M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091149 · Cited by 45
Self-citationFujieda, Y., Manno, A., Hayashi, Y., Rhodes, N., Guo, L., Arita, M., Bamba, T., & Fukusaki, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066270 · Cited by 44
“To avoid this, organisms have developed a mechanism to subside inflammation, namely, resolution of inflammation which is an active process rather than a passive process and mediated by chemical mediators [2].”
BackgroundRole of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game
Kumar, V., & Ahmad, A. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1380199 · Cited by 37
Bai, X., Putz, A. M., Wang, Z., Fortin, F., Harding, J. C. S., Dyck, M. K., Dekkers, J. C. M., Field, C. J., Plastow, G. S., & Canada, P. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00216 · Cited by 40
Butenko, S., Satyanarayanan, S. K., Assi, S., Schif‐Zuck, S., Barkan, D., Sher, N., & Ariel, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00405 · Cited by 39
“Upon the arrival of these leukocytes, mostly neutrophils, they primarily function to phagocytose and eliminate foreign microorganisms via distinct intracellular killing mechanisms, resulting in neutrophils undergoing programmed cell death (apoptosis) (1, 2).”
BackgroundEstradiol resolves pneumonia via ERβ in regulatory T cells
Xiong, Y., Zhong, Q., Palmer, T., Benner, A., Wang, L., Suresh, K. S., Damico, R. L., & D’Alessio, F. R. (2021) · JCI Insight · doi:10.1172/jci.insight.133251 · Cited by 39
“First, we focused on the resolution phase, a distinct stage with active immunological mechanisms (41, 42) that could offer new”
BackgroundResolvin E1 Regulates Th17 Function and T Cell Activation
Öner, F., Álvarez, C., Yaghmoor, W., Stephens, D. N., Hastürk, H., Fıratlı, E., & Kantarcı, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637983 · Cited by 42
“The resolution is critical for homeostatic balance to counteract the chronicity of inflammation (1, 2).”
BackgroundNam, J., Son, S., Park, K. S., & Moon, J. J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100093 · Cited by 37
Annexin A protein family in atherosclerosis
Li, Y., Wang, Y., Huang, L., Zhao, Y.-Y., Chen, L.-H., & Zhang, C. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.05.009 · Cited by 41
Kebir, D. E., József, L., & Filep, J. G. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0008-3 · Cited by 38
“This constitutively expressed cell-death program renders neutrophils unresponsive to pro-inflammatory stimuli and promotes their removal from inflamed areas by scavenger macrophages [98, 100] with minimal damage to the surrounding tissue, thereby facilitating the resolution of inflammation [35, 98, 103 , 104].”
BackgroundInflammation in Fabry disease: stages, molecular pathways, and therapeutic implications
Kurdi, H., Lavalle, L., Moon, J., & Hughes, D. A. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1420067 · Cited by 43
Molecular dynamics of inflammation resolution: therapeutic implications
Soliman, A. M., Soliman, M. M., Shah, S. S. H., Baig, H. A., Gouda, N. S., Alenezi, B. T., Alenezy, A. K., Hegazy, A. M. S., Jan, M., & Abdalla, E. H. E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1600149 · Cited by 45
“…is progressively distinguishing the terms “anti-inflammation” and “pro-resolution,” emphasizing the concept that resolution is an active process, facilitating restoration of tissue homeostasis and the transition from innate to adaptive immunity (Serhan et al., 2007; Buckley et al., 2014).”
Recent Developments in Chimeric NSAIDs as Safer Anti‐Inflammatory Agents
Suthar, S. K., & Sharma, M. (2014) · Medicinal Research Reviews · doi:10.1002/med.21331 · Cited by 37
ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland
Wang, C.-S., Wee, Y., Yang, C.-H., Melvin, J. E., & Baker, O. J. (2016) · Scientific Reports · doi:10.1038/srep24244 · Cited by 37
“Production of pro-inflammatory cytokines such as TNF-α , IL-6 and IFN-γ by local epithelial cells during acute inflammation lead to immune cell recruitment ( e.g . macrophages and lymphocytes) and promotion of healing 19,55 .”
Lipoxin A 4 stimulates endothelial miR‐126–5p expression and its transfer via microvesicles
Codagnone, M., Recchiuti, A., Lanuti, P., Pierdomenico, A. M., Cianci, E., Patruno, S., Mari, V. C., Simiele, F., Tomo, P. D., Pandolfi, A., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600952r · Cited by 39
“Ideally, the acute inflammatory response is self-limited, ending with the cessation of leukocyte, mainly polymorphonuclear neutrophil (PMN), infiltration, the clearance of apoptotic PMNs by monocyte-derived macrophages, and tissue repair (3).”
BackgroundHughes, E. L., Becker, F., Flower, R. J., Buckingham, J. C., & Gavins, F. N. E. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13847 · Cited by 42
“…controlled and active (rather than passive) resolution programs (Chiang et al., 2006; Serhan et al., 2008), in which efficient resolution depends on inhibition of neutrophil influx, rapid clearance of infiltrating neutrophils and regeneration of disrupted tissue structures (Serhan et al., 2007).”
BackgroundWinkler, J. W., Libreros, S., de la Rosa, X., Sansbury, B. E., Norris, P. C., Chiang, N., Fichtner, D., Keyes, G. S., Wourms, N., Spite, M. R., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mi0617-254r · Cited by 37
Self-citationAssociations between Dietary Patterns and Inflammatory Markers during Pregnancy: A Systematic Review
Yeh, K., Kautz, A., Lohse, B., & Groth, S. W. (2021) · Nutrients · doi:10.3390/nu13030834 · Cited by 47
“Researchers have found that deficiencies in dietary omega-3 fatty acids may result in insufficient precursors of pro-resolving mediators, leading to prolonged inflammation [94].”
BackgroundRegulation of in vivo delivery of nanomedicines by herbal medicines
Guan, J., Chen, W., Yang, M., Wu, E., Qian, J., & Zhan, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.015 · Cited by 37
Bannenberg, G. L. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.57 · Cited by 39
“An appealing hypothesis that is currently being assessed for its validity entails that derangement of counter-regulatory mechanisms to limit leukocyte infiltration or their activation, or failure of specific autacoids to initiate the resolution of inflammation, constitutes a cause of inflammatory disease[16,54].”
BackgroundRobertson, A. L., Ogryzko, N. V., Henry, K. M., Loynes, C. A., Foulkes, M. J., Meloní, M., Wang, X., Ford, C. T., Jackson, M. J., Ingham, P. W., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024935 · Cited by 44
Phytosterols in rice bran and their health benefits
Liu, Z., Liu, X., Ma, Z., & Guan, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1287405 · Cited by 42
Modeling of signaling pathways in chondrocytes based on phosphoproteomic and cytokine release data
Melas, I. N., Chairakaki, A. D., Chatzopoulou, E. I., Messinis, D. E., Katopodi, T., Pliaka, V., Samara, S., Mitsos, A., Dailiana, Z. H., Κollia, P., et al. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.01.001 · Cited by 36
Bioanalytical insights into mediator lipidomics
Kasuga, K., Suga, T., & Mano, N. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.02.011 · Cited by 37
Switching Off Key Signaling Survival Molecules to Switch On the Resolution of Inflammation
Perez, D., Vago, J. P., Athayde, R. M., Reis, A. C., Teixeira, M. M., Sousa, L. P., & Pinho, V. (2014) · Mediators of Inflammation · doi:10.1155/2014/829851 · Cited by 42
Subacute treatment of carprofen facilitate splenocardiac resolution deficit in cardiac injury
Halade, G. V., Kain, V., Wright, G. M., & Jadapalli, J. K. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0618-223r · Cited by 35
Specialized pro‐resolving lipid mediators in experimental periodontitis: A systematic review
Parra, M. M. O., Elangovan, S., & Lee, C. (2018) · Oral Diseases · doi:10.1111/odi.12979 · Cited by 37
Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation
Galvão, I., Melo, E. M., de Oliveira, V. L. S., Vago, J. P., Queiroz‐Junior, C. M., de Gaetano, M., Brennan, E. P., Gahan, K., Guiry, P. J., Godson, C., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105445 · Cited by 34
Is “cellular senescence” a misnomer?
Gems, D., & Kern, C. C. (2022) · GeroScience · doi:10.1007/s11357-022-00652-x · Cited by 35
Vago, J. P., Zaidan, I., Perucci, L. O., Brito, L. F., Teixeira, L. C. R., Silva, C. M. S., Miranda, T. C., Melo, E. M., Bruno, A. S., Queiroz‐Junior, C. M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.166044 · Cited by 40
“An important feature of the resolution of inflammation is the shift in macrophage phenotype from M1-like (pro-inflammatory) to M2-like (anti-inflammatory) (52, 53).”
Total synthesis of Resolvin E1
Allard, M. L., Barnes, K. D., Chen, X., Cheung, Y., Duffy, B. C., Heap, C. R., Inthavongsay, J., Johnson, M., Krishnamoorthy, R., Manley, C., et al. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.03.035 · Cited by 34
Grenon, S. M., Conte, M. S., Nosova, E. V., Alley, H. F., Chong, K. C., Harris, W. S., Vittinghoff, E., & Owens, C. D. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.05.024 · Cited by 42
Pashover‐Schallinger, E., Aswad, M., Schif‐Zuck, S., Shapiro, H., Singer, P., & Ariel, A. (2012) · The FASEB Journal · doi:10.1096/fj.11-194894 · Cited by 37
“Key Words: chemokine receptors apoptotic cell clearance acute immune responses leukocytes During the active resolution of inflammation (1, 2), immune response elements are eliminated (3).”
BackgroundDatabase Survey of Anti-Inflammatory Plants in South America: A Review
Lima, G. R. D. M., Montenegro, C. D. A., de Almeida, C. L. F., de Athayde-Filho, P. F., Barbosa‐Filho, J. M., & Batista, L. M. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12042692 · Cited by 34
“If this sequence of steps is rigorously followed, the acute inflammation will resolve without causing excessive damage to tissue, returning to homeostasis [3].”
BackgroundInfluentialDyke, T. E. V. (2014) · Journal of Periodontology · doi:10.1902/jop.2014.130701 · Cited by 34
Crosstalk between the plasminogen/plasmin system and inflammation resolution
Perucci, L. O., Vago, J. P., Miles, L. A., & Sousa, L. P. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.07.013 · Cited by 35
Zamora, A., Nougué, M., Verdu, L., Balzan, E., Draia-Nicolau, T., Benuzzi, E., Pujol, F., Baillif, V., Lacazette, E., Morfoisse, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-43554-y · Cited by 30
Glucocorticoid‐stimulated, transcription‐independent release of annexin A1 by cochlear Hensen cells
Kalinec, F., Webster, P. C., Maricle, A., Guerrero, D., Chakravarti, D., Chakravarti, B., Gellibolian, R., & Kalinec, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00473.x · Cited by 32
“To evaluate the potential glucocorticoid-induced release of LXA4 by cochlear spirals, we used a specific quantitative ELISA assay.”
BackgroundInfluentialSanz, M., Albertos, F., Otero, E., Juez, M., Morcillo, E. J., & Piqueras, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102942 · Cited by 38
“At present, there is enormous interest in dissecting the counterregulatory molecular mechanism activated by endogenous mediators to bring about inflammatory resolution and restoration of tissue homeostasis (17).”
BackgroundNovel translational model of resolving inflammation triggered by UV‐killed E. coli
Motwani, M. P., Flint, J., Maeyer, R. P. H. D., Fullerton, J. N., Smith, A. M., Marks, D. J., & Gilroy, D. W. (2016) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.43 · Cited by 40
“In contrast, cellular resolution, classically defined by reduction of neutrophil numbers [15], ensued gradually from 4 h, with >90% of neutrophils cleared by 48 h.”
BackgroundSelf-citationAswad, M., Assi, S., Schif‐Zuck, S., & Ariel, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1502542 · Cited by 39
Forsythoside A Modulates Zymosan-Induced Peritonitis in Mice
Zhang, X., Ding, Y., Kang, P., Zhang, X.-Y., & Zhang, X. (2018) · Molecules · doi:10.3390/molecules23030593 · Cited by 33
He, C., Yang, Z., Jin, Y., Qi, X., Chu, J., & Deng, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00657 · Cited by 39
“Skin-wound healing begins with a local immune response characterized by massive recruitment of immune cells (Serhan et al., 2007) and their production of pro-inflammatory cytokines, such as TNF-α and IFN-γ (Falanga et al.”
BackgroundApplication of specialized pro‐resolving mediators in periodontitis and peri‐implantitis: a review
Ali, M., Yang, F., Plachokova, A. S., Jansen, J. A., & Walboomers, X. F. (2021) · European Journal Of Oral Sciences · doi:10.1111/eos.12759 · Cited by 36
“Recent studies have confirmed that resolution of inflammation is an active process rather than a passive one, and this process is normally maintained by endogenous proresolution mediators (or agonists) [41].”
BackgroundLongen, S., Beck, K., & Pfeilschifter, J. M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.026 · Cited by 36
Than, N. G., Kim, S., Abbas, A., Han, Y. M., Hotra, J. W., Tarca, A. L., Erez, O., Wildman, D. E., Kusanovic, J. P., Pineles, B. L., et al. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00624.x · Cited by 35
Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study
Erdinest, N., Ovadia, H., Kormas, R. M., & Solomon, A. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-6 · Cited by 34
“It is now believed that an inflammatory process has 3 phases: onset, peak and resolution [14].”
BackgroundInfluentialMadelaire, C. B., Cassettari, B. D. O., & Gomes, F. R. (2018) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2018.09.005 · Cited by 32
Non-inflammatory Physiology of “Inflammatory” Mediators – Unalamation, a New Paradigm
Maddipati, K. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580117 · Cited by 36
“Any delay or lapse in the initiation of resolution could lead to an exacerbated state of inflammation and failure of the system to return to homeostasis (4).”
BackgroundAnti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium
Ciccone, V., Piragine, E., Gorica, E., Citi, V., Testai, L., Pagnotta, E., Matteo, R., Pecchioni, N., Montanaro, R., Mannelli, L. D. C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415593 · Cited by 36
Atherosclerosis: A redox-sensitive lipid imbalance suppressible by cyclopentenone prostaglandins
Gutierrez, L. L. P., Maslinkiewicz, A., Curi, R., & de Bittencourt, P. I. H. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.002 · Cited by 41
“Rather, their state resembles that of chronic inflammation, in which resolution phases are dysfunctional [4] and physiological feedback mechanisms that regulate intracellular cholesterol are overcome by constant noxious stimuli stated above which exacerbate the arterial wall lesion.”
BackgroundInfluentialLipopolysaccharide-induced Cyclooxygenase-2 Expression in Mouse Transformed Clara Cells
Britt, R. D., Locy, M. L., Tipple, T. E., Nelin, L. D., & Rogers, L. K. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000337602 · Cited by 32
Resolution of PMA-Induced Skin Inflammation Involves Interaction of IFN- γ and ALOX15
Zhang, G., Liu, X., Wang, C., Qu, L.-W., Deng, J., Wang, H., & Qin, Z. (2013) · Mediators of Inflammation · doi:10.1155/2013/930124 · Cited by 34
“Normally, the resolution phase of inflammation is characterized by the orderly phagocytic clearance of apoptotic granulocytes and debris by macrophages [5].”
BackgroundRegulation of Inflammatory Pathways in Cancer and Infectious Disease of the Cervix
Adefuye, A. O., & Sales, K. J. (2012) · Scientifica · doi:10.6064/2012/548150 · Cited by 39
Going, Toll-like receptors in skin inflammation and inflammatory diseases
Kumar, V. (2021) · EXCLI journal · doi:10.17179/excli2020-3114 · Cited by 53
sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae
Li, H., Bradbury, J. A., Edin, M. L., Graves, J. P., Gruzdev, A., Cheng, J., Hoopes, S. L., DeGraff, L. M., Fessler, M. B., Garantziotis, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci129679 · Cited by 35
“Emerging evidence suggests that lipid mediators are major regulators of both the amplitude and duration of infection-triggered inflammatory responses (8).”
BackgroundShay, A. E., Nshimiyimana, R., Samuelsson, B. O., Petasis, N. A., Haeggström, J. Z., & Serhan, C. N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116559118 · Cited by 33
Self-citationGallo, C. G., Fiorino, S., Posabella, G., Antonacci, D., Tropeano, A., Pausini, E., Pausini, C., Guarniero, T., Hong, W., Giampieri, E., et al. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106619 · Cited by 34
“Mediators and bioactive molecules, mainly derived from polyunsaturated fatty acids (PUFA) and known as specialized pro-resolving mediators (SPMs), modulate the action of several signaling pathways and control the self-resolution of inflammation [14].”
Cilibrizzi, A., Schepetkin, I. A., Bartolucci, G., Crocetti, L., Piaz, V. D., Giovannoni, M. P., Graziano, A., Kirpotina, L. N., Quinn, M. T., & Vergelli, C. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.043 · Cited by 31
Torres-Atencio, I., Ainsua‐Enrich, E., de Mora, F., Picado, C., & Martı́n, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110870 · Cited by 29
“In this context, it opposes the host inflammatory response, which potentially limits collateral damage to neighboring cells and tissues, thereby aiding the resolution of inflammation [20].”
BackgroundDrift-Diffusion Analysis of Neutrophil Migration during Inflammation Resolution in a Zebrafish Model
Holmes, G. R., Dixon, G., Anderson, S., Reyes‐Aldasoro, C. C., Elks, P. M., Billings, S. A., Whyte, M. K. B., Kadirkamanathan, V., & Renshaw, S. A. (2012) · Advances in Hematology · doi:10.1155/2012/792163 · Cited by 30
“Neutrophils recruited to sites of inflammation may leave the site or die in situ [1].”
BackgroundFonseca, F. C. D. S., Orlando, R. M., Turchetti-Maia, R. M. M., & Francischi, J. N. (2017) · Journal of Inflammation Research · doi:10.2147/jir.s142424 · Cited by 30
“28,29 In this study, we demonstrated that the exogenous administration of two such compounds, RvE1 and RvD1, was simultaneously anti-inflammatory (antiedemato-genic) and analgesic with varied efficacy when administered peripherally, that is, when administered locally in the rat hind paws.”
Pierdomenico, A. M., Patruno, S., Codagnone, M., Simiele, F., Mari, V. C., Plebani, R., Recchiuti, A., & Romano, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14055-y · Cited by 34
Pullen, A. B., Jadapalli, J. K., Rhourri‐Frih, B., & Halade, G. V. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09817-x · Cited by 30
Effect of carrageenans on some lipid metabolism components in vitro
Sokolova, E. V., Kravchenko, A. O., Sergeeva, N. V., Давыдова, В. Н., Богданович, Л. Н., & Yermak, I. M. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115629 · Cited by 32
Vago, J. P., Tavares, L. P., Riccardi, C., Teixeira, M. M., & Sousa, L. P. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111033 · Cited by 36
Fatty Acid Oxidation and Pro-Resolving Lipid Mediators Are Related to Male Infertility
Signorini, C., Moretti, E., Noto, D., Micheli, L., Ponchia, R., & Collodel, G. (2022) · Antioxidants · doi:10.3390/antiox11010107 · Cited by 34
“Resolvins facilitate and mediate the termination of inflammatory phases, which is an active rather than a passive process [40].”
BackgroundThe Tolerogenic Function of Annexins on Apoptotic Cells Is Mediated by the Annexin Core Domain
Linke, B., Abeler‐Dörner, L., Jahndel, V., Kurz, A., Mahr, A., Pfrang, S., Linke, L., Krammer, P. H., & Weyd, H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401299 · Cited by 30
A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?
Shields, A. M., Panayi, G. S., & Corrigall, V. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00017 · Cited by 32
AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
Wang, C., Maruyama, C. L., Easley, J. T., Trump, B., & Baker, O. J. (2017) · Scientific Reports · doi:10.1038/srep45525 · Cited by 32
Zhang, H., Lu, Y. W., Sun, G., Teng, F., Luo, N., Jiang, J., & Wen, A. (2017) · Critical Care · doi:10.1186/s13054-017-1757-3 · Cited by 30
“FPR2/ALX conveys proresolving properties by provoking detachment of neutrophils, facilitating neutrophil apoptosis, and promoting macrophage efferocytosis and release of anti-inflammatory cytokines [19].”
BackgroundMeital, L. T., Sandow, S. L., Calder, P. C., & Russell, F. D. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.02.001 · Cited by 30
“In the event that resolution fails to initiate, a state of chronic inflammation ensues [84].”
Fatahi, S., Pezeshki, M., Mousavi, S. M., Teymour, A., Rahmani, J., Kord‐Varkaneh, H., & Ghaedi, E. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.11.006 · Cited by 28
Xu, H., Chen, J., Ge, J., Xia, K., Tao, S., Su, Y., & Zhang, Q. (2019) · Journal of Endodontics · doi:10.1016/j.joen.2019.05.005 · Cited by 30
Impact of gut microbiota on plasma oxylipins profile under healthy and obesogenic conditions
Ávila‐Román, J., Arreaza‐Gil, V., Cortés-Espinar, A. J., Soliz‐Rueda, J. R., Mulero, M., Muguerza, B., Arola‐Arnal, A., Arola, L., & Torres‐Fuentes, C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.035 · Cited by 33
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial
Grenon, S. M., Owens, C. D., Alley, H. F., Chong, K. C., Yen, P. K., Harris, W. S., Hughes‐Fulford, M., & Conte, M. S. (2013) · Vascular Medicine · doi:10.1177/1358863x13503695 · Cited by 30
Qin, Y., Auh, S. L., Blokh, L., Long, C. G., Gagnon, I., & Hamann, K. J. (2007) · PubMed · Cited by 31
Gordon, S., & Plüddemann, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00010-3 · Cited by 29
Glucocorticoid-induced leucine zipper (GILZ) in immuno suppression: master regulator or bystander?
Hoppstädter, J., & Kiemer, A. K. (2015) · Oncotarget · doi:10.18632/oncotarget.6197 · Cited by 31
“On the other hand, excessive activation of the anti-inflammatory cascades might lead to severe immunosuppression [1, 2].”
BackgroundE-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae
Aronoff, D. M., Bergin, I. L., Lewis, C. A., Goel, D., O’Brien, E., Peters-Golden, M. L., & Mancuso, P. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.03.002 · Cited by 28
McMillan, D. H., Woeller, C. F., Thatcher, T. H., Spinelli, S. L., Maggirwar, S. B., Sime, P. J., & Phipps, R. P. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00352.2012 · Cited by 34
Defensin Production by Human Limbo-Corneal Fibroblasts Infected with Mycobacteria
Castañeda‐Sánchez, J. I., García‐Pérez, B. E., Muñóz-Duarte, A. R., Baltierra‐Uribe, S. L., Mejía-López, H., López-López, C., Lucio, V. B.-D., Robles-Contreras, A., & Luna‐Herrera, J. (2013) · Pathogens · doi:10.3390/pathogens2010013 · Cited by 32
“These cells not only remodel the extracellular matrix but also actively participate in the regulation of selftolerance, organ development, and inflammatory processes [22,23].”
BackgroundAndrade, M. E. R., de Barros, P. A. V., Menta, P. L. D. R., Costa, G. M. F., Miranda, S. E. M., Leocádio, P. C. L., Almeida‐Leite, C. M., Generoso, S. D. V., Leite, J. I. A., & Cardoso, V. N. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.019 · Cited by 27
ROCK Inhibition Drives Resolution of Acute Inflammation by Enhancing Neutrophil Apoptosis
Galvão, I., Athayde, R. M., Perez, D., Reis, A. C., Rezende, L., de Oliveira, V. L. S., Rezende, B. M., Gonçalves, W. A., Sousa, L. P., Teixeira, M. M., et al. (2019) · Cells · doi:10.3390/cells8090964 · Cited by 33
“This is a relevant fact, since mononuclear cells are very important during the resolution process by secreting anti-inflammatory and/or pro-resolutive mediators and by phagocytosing apoptotic cells [6,67].”
BackgroundUnderstanding Resolvin Signaling Pathways to Improve Oral Health
Keinan, D., Leigh, N. J., Nelson, J. W., Oleo, L. D., & Baker, O. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035501 · Cited by 31
“Resolvins enhance and restore tissue integrity, since they possess both anti-inflammatory and pro-resolution mechanisms [76].”
BackgroundMechanisms underlying the anti‐inflammatory activity and gastric safety of acemetacin
Chávez‐Piña, A. E., McKnight, W., Dicay, M. S., Castañeda‐Hernández, G., & Wallace, J. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707451 · Cited by 27
“As reported by others, the resolution of inflammation in this model could be driven by the generation of anti-inflammatory substances, such as PGD2, lipoxins and resolvins (Gilroy et al., 1999; Serhan et al., 2007).”
BackgroundSelf-citationA Novel Thermoresponsive Gel as a Potential Delivery System for Lipoxin
Wang, B., Shao, J., Jansen, J. A., Walboomers, X. F., & Yang, F. (2018) · Journal of Dental Research · doi:10.1177/0022034518810213 · Cited by 28
“Uncontrolled inflammation and failed resolution of the inflammation are considered the underlying mechanism of periodontitis (Van Dyke and Serhan 2003; Serhan et al. 2007; Medzhitov 2010; Serhan 2010).”
BackgroundMakni, S., Tounsi, S., Rezgui, F., Trigui, M., & Bouassida, K. Z. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.12.015 · Cited by 35
Control of Myeloid Cell Trafficking in Resolution
Norling, L. V., & Perretti, M. (2013) · Journal of Innate Immunity · doi:10.1159/000350612 · Cited by 29
Self-citationPolyunsaturated fatty acids and peripheral artery disease
Grenon, S. M., Hughes‐Fulford, M., Rapp, J. H., & Conte, M. S. (2012) · Vascular Medicine · doi:10.1177/1358863x11429175 · Cited by 30
Taşkan, M. M., Yüce, H. B., Karataş, Ő., Gevrek, F., & Toker, H. Ç. (2019) · Journal of Periodontal Research · doi:10.1111/jre.12662 · Cited by 27
Functions of the plasminogen receptor Plg‐RKT
Miles, L. A., Vago, J. P., Sousa, L. P., & Parmer, R. J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15014 · Cited by 41
Shoieb, S. M., El‐Ghiaty, M. A., & El‐Kadi, A. O. S. (2020) · Emergent Materials · doi:10.1007/s42247-020-00136-8 · Cited by 27
Hartlev, J., Schou, S., Isidor, F., & Nørholt, S. E. (2021) · International Journal of Implant Dentistry · doi:10.1186/s40729-021-00289-z · Cited by 27
“The above-mentioned patients were the only two patients (2/25 patient) in which their bone biopsy was characterized by moderate to heavy inflammation, indicating that the bone resorption and thereby the periimplant marginal bone level are associated with resolution of the inflammatory process [42].”
BackgroundBarioni, É. D., Santin, J. R., Machado, I. D., Rodrigues, S. F., Ferraz-de-Paula, V., Wagner, T. M., Cogliati, B., dos Santos, M. C., Machado, M. D. S., de Andrade, S. F., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/787916 · Cited by 27
Resolvin E1 as a novel agent for the treatment of asthma
Hisada, T., Ishizuka, T., Aoki, H., & Mori, M. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902865622 · Cited by 29
“The resolution of inflammation was defined in modern molecular terms [32], and is now considered to be a distinct process from the antiinflammatory process [32].”
BackgroundChronic inflammation in asthma: a contest of persistence vs resolution
Hove, C. V., Maes, T., Joos, G., & Tournoy, K. (2008) · Allergy. European Journal of Allergy and Clinical Immunology · doi:10.1111/j.1398-9995.2008.01772.x · Cited by 33
“Resolution of inflammation is an active process, which prevents unnecessary tissue damage after clearance of the inflammatory stimulus (3, 4).”
BackgroundSaito, T., Hasegawa‐Moriyama, M., Kurimoto, T., Yamada, T., Inada, E., & Kanmura, Y. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000892 · Cited by 26
Randolph, G. J. (2011) · Science · doi:10.1126/science.1208480 · Cited by 26
Wang, R. X., & Colgan, S. P. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.02.002 · Cited by 30
“Thus, resolution of inflammation involving the removal of cellular debris and restoration of tissue integrity is equally crucial (Kumar et al., 2014; Medzhitov, 2008; Serhan et al., 2007).”
Background
Metadata
- Authors
- Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L.
- Affiliations
- Brigham and Women's Hospital (US)
- King's College London (GB)
- University of Birmingham (GB)
- University College London (GB)
- Centre for Inflammation Research (GB)
- Trinity College Dublin (IE)
- Queen Mary University of London (GB)
- University of Calgary (CA)
- Corresponding author
- Serhan, Charles N.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-02
- Volume
- 21
- Issue
- 2
- Pages
- 325-332
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3119634
- OpenAlex
- W2120699390
- Cited by
- 1,045
- References
- 36
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 30 · 2023: 46 · 2022: 42 · 2021: 59 · 2020: 70 · 2019: 53 · 2018: 57 · 2017: 59 · 2016: 57 · 2015: 66 · 2014: 65 · 2013: 90 · 2012: 74
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Norges Idrettshøgskole
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- inflammation resolution, acute inflammation, anti-inflammatory agents, inflammation-associated diseases
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Leukocytes, Models, Biological, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.